164 related articles for article (PubMed ID: 29114905)
1. Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after all.
Chin WK
J Clin Pharm Ther; 2018 Feb; 43(1):159-162. PubMed ID: 29114905
[TBL] [Abstract][Full Text] [Related]
2. A systematic review on the off-label use of montelukast in atopic dermatitis treatment.
Chin WK; Lee SWH
Int J Clin Pharm; 2018 Oct; 40(5):963-976. PubMed ID: 29777328
[TBL] [Abstract][Full Text] [Related]
3. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
Yanase DJ; David-Bajar K
J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
Angelova-Fischer I; Tsankov N
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis.
Broshtilova V; Gantcheva M
Dermatol Ther; 2010; 23(1):90-3. PubMed ID: 20136913
[TBL] [Abstract][Full Text] [Related]
6. [A leukotriene antagonist (montelukast) in the treatment of atopic dermatitis in pediatric patients].
Concha del Río LE; Arroyave CM
Rev Alerg Mex; 2003; 50(5):187-91. PubMed ID: 14631590
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of montelukast in the treatment of atopic dermatitis.
Rahman ML; Choudhury AM; Islam MM
Mymensingh Med J; 2006 Jan; 15(1):85-8. PubMed ID: 16467770
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults.
Capella GL; Grigerio E; Altomare G
Eur J Dermatol; 2001; 11(3):209-13. PubMed ID: 11358726
[TBL] [Abstract][Full Text] [Related]
9. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
Veien NK; Busch-Sørensen M; Stausbøl-Grøn B
J Am Acad Dermatol; 2005 Jul; 53(1):147-9. PubMed ID: 15965438
[TBL] [Abstract][Full Text] [Related]
10. Montelukast can reduce the severity and extent of atopic dermatitis.
Holme H; Winckworth LC
J Paediatr Child Health; 2013 May; 49(5):412-5. PubMed ID: 23647765
[No Abstract] [Full Text] [Related]
11. Leukotriene receptor antagonists--a novel therapeutic approach in atopic dermatitis?
Kägi MK
Dermatology; 2001; 203(4):280-3. PubMed ID: 11752812
[TBL] [Abstract][Full Text] [Related]
12. Severe erythrodermic atopic dermatitis treated with montelukast.
Broshtilova V; Antonov D; Bardarov E; Tsankov N
Skinmed; 2003; 2(2):134-6. PubMed ID: 14673317
[No Abstract] [Full Text] [Related]
13. Efficacy and tolerability of montelukast as a therapeutic agent for severe atopic dermatitis in adults.
Nettis E; Pannofino A; Fanelli M; Ferrannini A; Tursi A
Acta Derm Venereol; 2002; 82(4):297-8. PubMed ID: 12361137
[No Abstract] [Full Text] [Related]
14. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
15. Brief case series: montelukast, at doses recommended for asthma treatment, reduces disease severity and increases soluble CD14 in children with atopic dermatitis.
Hon KL; Leung TF; Ma KC; Wong Y; Fok TF
J Dermatolog Treat; 2005 Feb; 16(1):15-8. PubMed ID: 15897161
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene receptor antagonists are ineffective for severe atopic dermatitis.
Silverberg NB; Paller AS
J Am Acad Dermatol; 2004 Mar; 50(3):485-6. PubMed ID: 14988703
[No Abstract] [Full Text] [Related]
17. [Leukotriene antagonist. All around talent in asthma and allergies].
MMW Fortschr Med; 2002 Nov; 144(47):64. PubMed ID: 12532531
[No Abstract] [Full Text] [Related]
18. Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study.
Pei AY; Chan HH; Leung TF
Pediatr Allergy Immunol; 2001 Jun; 12(3):154-8. PubMed ID: 11473680
[TBL] [Abstract][Full Text] [Related]
19. Montelukast in general pediatric practices.
Ngamphaiboon J
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
[TBL] [Abstract][Full Text] [Related]
20. Emerging therapies for atopic dermatitis: The prostaglandin/leukotriene pathway.
Yanes DA; Mosser-Goldfarb JL
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S71-S75. PubMed ID: 29248523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
